A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score

被引:890
作者
Barbar, S.
Noventa, F. [2 ]
Rossetto, V.
Ferrari, A.
Brandolin, B.
Perlati, M.
De Bon, E.
Tormene, D.
Pagnan, A.
Prandoni, P. [1 ]
机构
[1] Univ Padua, Thromboembolism Unit, Dept Cardiothorac & Vasc Sci, Div Internal Med 2, I-35128 Padua, Italy
[2] Univ Padua, Clin Epidemiol Grp, Dept Clin & Expt Med, I-35128 Padua, Italy
关键词
anticoagulation; deep vein thrombosis; medical patients; prophylaxis; pulmonary embolism; risk assessment; venous thromboembolism; PULMONARY-EMBOLISM; D-DIMER; PROPHYLAXIS; PREVENTION; PLACEBO; THROMBOPROPHYLAXIS; REGISTRY;
D O I
10.1111/j.1538-7836.2010.04044.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Prophylaxis of venous thromboembolism (VTE) in hospitalized medical patients is largely underused. We sought to assess the value of a simple risk assessment model (RAM) for the identification of patients at risk of VTE. Methods: In a prospective cohort study, 1180 consecutive patients admitted to a department of internal medicine in a 2-year period were classified as having a high or low risk of VTE according to a predefined RAM. They were followed-up for up to 90 days to assess the occurrence of symptomatic VTE complications. The primary study outcome was to assess the adjusted hazard ratio (HR) of VTE in high-risk patients who had adequate in-hospital thromboprophylaxis in comparison with those who did not, and that of VTE in the latter group in comparison with low-risk patients. Results: Four hundred and sixty-nine patients (39.7%) were labelled as having a high risk of thrombosis. VTE developed in four of the 186 (2.2%) who received thromboprophylaxis, and in 31 of the 283 (11.0%) who did not (HR of VTE, 0.13; 95% CI, 0.04-0.40). VTE developed also in two of the 711 (0.3%) low-risk patients (HR of VTE in high-risk patients without prophylaxis as compared with low-risk patients, 32.0; 95% CI, 4.1-251.0). Bleeding occurred in three of the 186 (1.6%) high-risk patients who had thromboprophylaxis. Conclusions: Our RAM can help discriminate between medical patients at high and low risk of VTE. The adoption of adequate thromboprophylaxis in high-risk patients during hospitalization leads to longstanding protection against thromboembolic events with a low risk of bleeding.
引用
收藏
页码:2450 / 2457
页数:8
相关论文
共 27 条
[1]   Risk factors for venous thromboembolism [J].
Anderson, FA ;
Spencer, FA .
CIRCULATION, 2003, 107 :I9-I16
[2]   Identifying acutely ill medical patients requiring thromboprophylaxis [J].
Chopard, P ;
Spirk, D ;
Bounameaux, H .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (04) :915-916
[3]   Venous thromboembolism prophylaxis in acutely ill medical patients:: definite need for improvement [J].
Chopard, P ;
Dörffler-Melly, J ;
Hess, U ;
Wuillemin, WA ;
Hayoz, D ;
Gallino, A ;
Bachli, EB ;
Canova, CR ;
Isenegger, J ;
Rubino, R ;
Bounameaux, H .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (04) :352-357
[4]   Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study [J].
Cohen, Alexander T. ;
Tapson, Victor F. ;
Bergmann, Jean-Francois ;
Goldhaber, Samuel Z. ;
Kakkar, Ajay K. ;
Deslandes, Bruno ;
Huang, Wei ;
Zayaruzny, Maksim ;
Emery, Leigh ;
Anderson, Frederick A., Jr. .
LANCET, 2008, 371 (9610) :387-394
[5]   Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality [J].
Cohen, Alexander T. ;
Agnelli, Giancarlo ;
Anderson, Frederick A. ;
Arcelus, Juan I. ;
Bergqvist, David ;
Brecht, Josef G. ;
Greer, Ian A. ;
Heit, John A. ;
Hutchinson, Julia L. ;
Kakkar, Ajay K. ;
Mottier, Dominique ;
Oger, Emmanuel ;
Samama, Meyer-Michel ;
Spannagl, Michael .
THROMBOSIS AND HAEMOSTASIS, 2007, 98 (04) :756-764
[6]   Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial [J].
Cohen, AT ;
Davidson, BL ;
Gallus, AS ;
Lassen, MR ;
Prins, MH ;
Tomkowski, W ;
Turpie, AGG ;
Egberts, JFM ;
Lensing, AWA .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7537) :325-327
[7]   Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients [J].
Cohen, AT ;
Alikhan, R ;
Arcelus, JI ;
Bergmann, JF ;
Haass, S ;
Merli, G ;
Spyropoulos, AC ;
Tapson, VF ;
Turpie, AGG .
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (04) :750-759
[8]   The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism [J].
Douketis, James D. ;
Gu, Chu Shu ;
Schulman, Sam ;
Ghirarduzzi, Angelo ;
Pengo, Vittorio ;
Prandoni, Paolo .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (11) :766-U36
[9]   Prophylaxis for thromboembolism in hospitalized medical patients [J].
Francis, Charles W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (14) :1438-1444
[10]   Prevention of venous thromboembolism [J].
Geerts, William H. ;
Bergqvist, David ;
Pineo, Graham F. ;
Heit, John A. ;
Samama, Charles M. ;
Lassen, Michael R. ;
Colwell, Clifford W. .
CHEST, 2008, 133 (06) :381S-453S